Bharat Biotech s new variant of vaccine gets WHO pre-qualification thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
Centre defends its Covid vaccine policy
K.C.Gopakumar
Kochi |
Updated on
Pricing, procurement and administration of vaccines to be made more flexible
The Centre has informed the Kerala High Court that its new Liberalized Pricing and Accelerated National Covid-19 Vaccination Strategy is aimed at incentivising the vaccine manufacturers to rapidly scale up their production and to attract new vaccine manufacturers.
In a statement filed in response to a few petitions challenging the liberalised pricing policy, the Centre submitted that it would make pricing, procurement and administration of vaccines more flexible and ensure augmented vaccine production as well as wider availability of vaccines in the country.
Centre defends liberalised pricing of COVID vaccines
Updated:
Updated:
To incentivise manufacturers to scale up production and attract new ones
Share Article
To incentivise manufacturers to scale up production and attract new ones
The Centre on Monday informed the Kerala High Court that its new liberalised pricing and accelerated national COVID-19 vaccination strategy was aimed at incentivising vaccine manufacturers to rapidly scale up their production and attract new vaccine manufacturers.
In a statement filed in response to a public interest litigation challenging the liberalised pricing policy, the Centre submitted that the strategy would make pricing, procurement, and administration of vaccines more flexible and ensure augmented vaccine production as well as wider availability of vaccines in the country.
COVID-19: Covaxin production to increase to 10 crore doses per month by September
The Centre is providing financial support as grant to vaccine manufacturing facilities to enhance their production capacities.
BusinessToday.In | April 16, 2021 | Updated 17:59 IST
The government is taking steps under Atmanirbhar Bharat 3.0 Mission COVID Suraksha to accelerate production of indigenous vaccines.
As the surge in COVID-19 cases continues in the country, the Centre on Friday said it is taking steps to boost production of indigenous COVID-19 vaccines, and the production capacity of Bharat Biotech s COVID-19 vaccine Covaxin will increase to 10 crore doses per month by September.
The government is taking steps under Atmanirbhar Bharat 3.0 Mission COVID Suraksha to accelerate the development and production of indigenous vaccines. The Centre s Department of Biotechnology is providing financial support as grant to vaccine manufacturing facilities to enhance their production capacities, a r
Anna varsity suspends two PG programmes
Updated:
Updated:
Move due to conflicting quota rules
Share Article
Move due to conflicting quota rules
Anna University has suspended admissions to two M. Tech programmes for which students were eligible for scholarship from the Centre’s Department of Biotechnology (DBT), as the rules of reservation governing admissions to these courses were in conflict with the State’s communal reservation rules.
In a circular on its website, the university announced that M. Tech in Biotechnology and M. Tech in Computation Biology programmes would not be offered this year. As the Central government’s rules of reservation were not acceptable to Tamil Nadu, the university was unable to proceed with admissions to the courses, the circular said.